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Introduction and aim of study: there is recent evidence that the immune system plays an essential role in the
pathogenesis of atherosclerosis, with both cellular and humoral mechanisms being involved. Heat-shock proteins (HSPs)
have been detected in atherosclerotic lesions, and antibodies to HSPs have also been found to be raised in patients with
carotid stenoses. The aim of our study was to examine the level of anti-HSP70 antibodies in patients with other vascular
diseases.
Materials and methods: a questionnaire was designed for the subjects in the study, with documentation of clinical
details and ankle–brachial pressure index. Patients with concomitant infection, malignancy, hepatorenal failure, or recent
surgery were excluded. Enzyme-linked immunosorbent assay (ELISA) was used to identify anti-HSP70 antibodies in the
sera in different dilutions. Graphs of optical density (OD) vs. negative log dilution were plotted, the gradient of which
was taken to be the estimated optical density for each subject (proportional to antibody level). Our groups consisted of
controls (n=21, mean age 59.0–19.2), lower limb claudicants (n=19, mean age 60.0–12.6), patients with lower-limb
critical ischaemia (n=22, mean age 68.5–10.07), and patients with abdominal aortic aneurysms (n=20, mean age
69.9–6.2).
Results: we found no correlation between age and the estimated OD in our subjects (Spearman’s correlation coefficient
(r)=0.123, one-tailed p value was 0.135). Patients with intermittent claudication, critical lower limb ischaemia, and
aneurysms had higher estimated OD, and therefore higher anti-HSP70 antibody levels, than controls (Mann–Whitney
test; p=0.0127, 0.0037, 0.0008, respectively).
Conclusions: our data provide the first evidence of a correlation between anti-HSP70 antibodies and different types of
vascular diseases, suggesting that HSP70 might be involved in the pathogenesis and propagation of atherosclerosis. Since
the immune response to HSPs can be modulated, this opens up the possibility of new therapeutic approaches.
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Introduction through folding and unfolding steps, to eventually
achieve a functional conformation,6 and are sometimes
referred to as molecular chaperones. They assist inHeat-shock proteins (HSPs) are a highly conserved
the translocation and delivery of newly synthesisedgroup of proteins found in all organisms from the
proteins along proper secretory pathways;7,8 and aresimplest prokaryotes to the most complex multicellular
also involved in the translocation of glucocorticoidorganisms.1 They are classified according to their mo-
receptors from the cytoplasm to the nucleus.9 A mem-lecular weight, sequence homologies and antigenic
ber of the HSP70 family also plays a role in antigencross-reactivities.1 Although the synthesis of these pro-
presentation.10–12 In a stress response, the induction ofteins is increased in response to many environmental
HSPs is remarkably rapid and intense.stresses,2–4 they are expressed at low levels under
HSP70 is induced in vivo in response to localisednormal physiological conditions, and play vital roles
injury such as in head injury,13 spinal cord injury,14,15in maintaining cell functions.5
and in reperfusion injury.16,17 Antibodies to HSP70Members of the HSP70 kDa family are essential in
are also elevated in certain chronic disease states inensuring that nascent polypeptides proceed correctly
humans such as systemic lupus erythematosis,
thyroiditis, rheumatoid arthritis, and in type 1 diabetes
* Please address all correspondence to: G. Stansby, Academic Sur-
mellitus.18,19 Since the early 1990s, HSP70 has beengical Unit, 10th Floor QEQM Building, Imperial College School of
Medicine at St. Mary’s, Praed Street, London W2 1NY, U.K. detected in human aortic and carotid plaques, where
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it is present together with macrophages in necrotic linked immunosorbent assay (ELISA) technique was
used to identify anti-HSP70 antibodies in the serum.areas.20 The distribution of HSP70 is uneven in these
lesions, and seems to correspond with areas of in- Each sample was diluted 1:50, 1:100, 1:500, 1:1000, and
assayed in triplicate. For each batch of assay, a samplecreased intimal thickness.21 This may be due to a
leakage of HSP70 from damaged cells and by secretion that was included in the previous assay was included.
The triplicate absorbency was averaged in each of theinto the plaque. Furthermore, advanced necrotic le-
sions have been shown to contain significantly more 4 dilutions for each sample. A graph of optical density
against the negative logarithm of the dilution was thenHSP70 than fibrotic lesions with a similar cell number.22
It has also been shown that there is a significant plotted for each of the subjects. The slope of the linear
regression line is the estimated OD for each subject,correlation between circulating levels of antibodies to
other HSPs such as HSP65 and carotid and coronary which is directly proportional to the level of anti-
HSP70 antibody.24,25atherosclerosis, and that the occurrence of such anti-
bodies was independent of classical risk factors such
as high blood pressure, cholesterol status or smoking.23
With the background knowledge that HSP70 may be Statistical Methods
important in the initiation and propagation of athero-
sclerosis, the aim of this study was to examine the Intergroup comparisons were with the Mann–Whitney
level of antibodies to HSP70 in patients with different U-test, with use of the Bonferroni correction factor for
types of vascular diseases, and to compare this against multiple comparisons where appropriate.
the levels found in normal age-matched controls.
Methods and Materials Results
Patients The demographic details of the subjects are shown in
Table 1. The proportions of smokers and patients with
A questionnaire was designed for patients and con- chronic hypertension were similar in each group. Anti-
trols, with clear documentation of clinical details, and HSP70 antibodies were present in all our subjects and
past medical history. Patients with concomitant in- controls. The estimated OD for controls was
fection, malignant disease, diabetes mellitus, severe 0.1859–0.0167 (mean–standard error of means), for
renal failure, and signs and symptoms of severe on- claudicants 0.2601–0.02161, for patients with critical
going inflammation, or recent surgery within the past ischaemia 0.3024–0.0310, and for patients with ab-
six months, were excluded from the study. The ankle– dominal aortic aneurysms 0.2880–0.0226 (Fig. 1).
brachial pressure index (ABPI) was measured, together Patients with different types of vascular diseases con-
with careful documentation of the presence or absence sidered together (n=61) had significantly higher levels
of ulceration or gangrene. Our controls were subjects of anti-HSP70 antibodies as compared to controls (p=
with no history of arterial disease, and were drawn 0.0003). Taken individually, when compared to con-
from those attending the general surgical out-patient trols, the p values for claudicants, critical ischaemics,
clinic with non-acute conditions. We studied 21 con- and aneurysm patients were also statistically sig-
trols (mean age 59.0–19.2), 20 patients with abdominal nificant (p=0.0127, 0.0037, and 0.0008, respectively,
aortic aneurysms (mean age 69.9–6.2), 19 patients Mann–Whitney U-test with Bonferroni correction fac-
with lower-extremity intermittent claudication (mean tor.) There were no significant differences in the levels
age 60.0–12.6), and 22 patients with lower-limb critical of anti-HSP70 antibodies between claudicants and crit-
ischaemia (mean age 68.5–10.07). Critical ischaemia ical ischaemics (p=0.4329).
was defined as the presence of vascular rest pain for When all subjects (n=82) were taken together, there
a duration of more than two weeks, not relieved by was no correlation between age and the estimated OD,
simple analgesia or dependency, and with an ankle (Spearman correlation coefficient of 0.12, 1-tail p-value
pressure of <50 mmHg. Subjects with gangrene or of 0.135 (Fig. 2)).
ischaemic ulceration were excluded.
Enzyme-linked immunosorbent assay (ELISA) Discussion
Venous blood was collected from the subjects, cent- Our study provides the first report of a correlation
between the level of anti-HSP70 antibodies and therifuged and the serum stored at -70 °C. An enzyme-
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Table 1. Patients’ demographics
Controls Claudicants Critical ischaemics AAA
n 21 19 22 20
Sex (M:F) 11:10 12:7 11:11 17:3
Age 59.0–19.2 60.0–12.6 68.5–10.1 69.9–6.2
Smoking 12 9 11 8
Blood pressure >140 mmHg 13 11 9 10
atherosclerosis, or the cellular response to it. This
finding appeared to be independent of the age of the
subjects.
Other studies have shown that the level and dis-
tribution of HSP70 correlates with changes in ath-
erosclerotic plaque, and that HSP70 levels can affect
endothelial cell function.20–22,26 There is also evidence
that while antibodies to HSP70 are absent in pathogen-
free animals kept in a sterile environment, they are
present in the circulation of healthy human sub-
jects,27 and that the induction of anti-HSP70 antibodies
may possibly be dependent on infection.28
HSP70 expression in rat aorta is markedly increased
in acute stress,29 suggesting that this HSP may have
cytoprotective and homeostatic roles against different
haemodynamic stresses.30 This is associated with the
expression of immediate–early response genes such as
Fig. 1. Levels of anti-HSP70 antibodies, expressed as mean estimated c-fos, and c-jun,31 which form the hetero-dimer AP-1optical density, in controls (n=21), claudicants (n=19), patients
that acts as a transcription factor for cell proliferation,with critical ischaemia (n=22), and patients with abdominal aortic
aneurysms (n=20) (Mann–Whitney U-test: * p<0.05, ** p<0.01). again indicating that it might also be involved in
the proliferation of vascular smooth-muscle cells in
response to stress.32
Apart from its cyto-protective roles, HSP70 seems
to be a double-edged sword: circulating anti-HSP70
antibodies may bind to vascular cells that have already
expressed HSP on their surfaces due to various stress.
This could also involve antigenic mimicry with
immunological cross-reactions between exogenous
materials (for instance, HSPs in micro-organisms such
as Chlamydia pneumoniae33) and auto-antigens.34 Ath-
erosclerotic lesions labelled with immuno-fluorescence
showed high levels of HSPs in endothelial cells, macro-
phages and smooth-muscle cells.23 Affinity chromato-
graphy demonstrated that purified human antibodies
against heat-shock protein 65 were cytotoxic to endo-
thelial cells, and that heat-shocked endothelial cells
could be lysed by these antibodies in the presence ofFig. 2. Graph of age of all subjects (n=82) vs. estimated OD: there
was no correlation between age and the estimated OD (Spearman complement via complement mediated cytotoxity, or
correlation coefficient of 0.12, 1-tail p-value of 0.135). in the presence of peripheral blood mononuclear cells
via antibody-dependent cellular toxicity.35
A two-staged model for the formation of ath-presence of vascular disease. This increase in levels of
erosclerotic lesions involving HSPs may, therefore, beanti-HSP70 antibodies was found in both patients
postulated. The first stage is caused by the productionwith claudication, critical ischaemia and in those with
of HSPs by endothelium, augmented by various typesaneurysmal disease, suggesting that HSP70 may be
involved in either the pathogenesis or propagation of of stressors. These stressors reveal epitopes of HSPs
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the cellular accumulation of stress (heat shock) mRNAs andon the endothelial cell surfaces, and are then subjected
proteins. J Virol 1982; 44: 703–707.to reactions by the cellular and humoral immune 3 Kurtz S, Rossi J, Petko L, Lindquist S. An ancient de-
system that are specific to these epitopes, causing velopmental induction: heat shock proteins induced in sporu-
lation and oogenesis. Science 1986; 231: 1154–1157.endothelial damage, and subsequently initiating the
4 Lanks KW. Modulators of the eukaryotic heat shock response.development of early (potentially reversible) ath- Exp Cell Res 1986; 165: 1–10.
erosclerotic lesions, containing monocytes, lym- 5 Pelham HR. Heat shock and the sorting of luminal ER proteins.
EMBO J 1989; 8: 1154–1156.phocytes and smooth-muscle cells.36 The second stage,
6 Hemmingsen SM, Woolford C, van der Vries SM et al.characterised by the appearance of foam cells and the Homologous plant and bacterial protein chaperone oligomeric
development of the persistent lesions, would pre- protein assembly. Nature 1988; 333: 300–304.
7 Chirico WJ, Waters MG, Blobel J. 70k heat shock relatedsumably occur only when other risk factors, such as
protein stimulates protein translocation into microsomes. Naturehypercholesterolaemia, coexist. Furthermore, it has 1988; 332: 805–810.
been shown that the application of various kinds 8 Deshaies RJ, Koch BD, Werner-Washburne M, Craig EA,
Schekman R. A subfamily of stress proteins facilitates trans-of vasoactive and pro-atherogenic stressors (such as
location of secretory and mitochondrial precursor polypeptides.tumour necrotic factor, interleukin-1, gamma-in-
Nature 1988; 332: 800–805.
terferon and oxidised low-density lipoproteins) to 9 Baulieu E, Catelli M. Steroid hormone receptors and heat
shock protein Mr 90,000 (HSP90): a functional interaction. In:endothelial cells can result in the surface expression
Pardue M, Feramisco J, Lindquist S, eds Stress Induced Proteins.of heat shock protein,37,38 and adhesion molecules,
New York: Alan R Liss, Inc., 1989: p. 275.
such as intercellular adhesion molecule-1 (ICAM-1), 10 Lakey EK, Margoliash E, Pierce SK. Identification of a peptide
binding protein which plays a role in antigen presentation. Procendothelial leukocyte adhesion molecule-1 (ELAM-1),
Natl Acad Sci USA 1987; 84: 1659–1663.and vascular cell adhesion molecule-1 (VCAM-1).39
11 Vanbuskirk AM, Crump BL, Margoliash E, Pierce SK. A
This provides the prerequisites for a cellular immune peptide binding protein having a role in antigen presentation is
a member of the HSP70 heat shock family. J Exp Med 1989; 170:reaction against surface-expressed heat-shock pro-
1799–1809.teins, with subsequent establishment of inflammatory
12 Pierce SK, DeNagel DC, Vanbuskirk AM. A role for heatfoci in the intima in the initial stages of atherosclerosis. shock proteins in antigen processing and presentation. Curr Top
In addition, antibodies to HSPs can penetrate injured Microbiol Immunol 1991; 167: 83–92.
13 Blake MJ, Nowak TS, Holbrook NJ. In vivo hyperthermiacells and specifically bind the intracellular heat shock
induces expression of HSP70 mRNA in brain regions controllingproteins in macrophages and foam cells, resulting in the neuro-endocrine response to stress. Mol Brain Res 1990; 8:
cell lysis. This may contribute to the formation of the 89–92.
14 Sakurai M, Aoki M, Abe K, Sadahiro M, Tabayashi K. Selectivenecrotic core found in more advanced atherosclerotic
motor neurone death and heat shock protein induction afterplaques. HSP70 can also be exchanged between cells, spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg 1997;
and there is evidence to suggest that HSPs’ effects 113: 159–164.
15 Sakurai M, Hayashi T, Abe K, Aoki M, Sadahiro M, Tabayashimay not be limited to the stressed cells synthesising
K. Enhancement of heat shock protein expression after transientthem.40,41 This might have important implication in ischemia in the preconditioned spinal cord of rabbits. J Vasc Surg
atherosclerosis, since cells types that are not directly 1998; 27: 720–725.
16 Gower DJ, Hollman C, Lee KS, Tytell MT. Spinal injury andinvolved by stressors will also be affected.
the stress protein response. J Neurosurg 1989; 70: 605–611.This study has shown that there is a correlation 17 Knowlton AA, Brecher P, Apstein S, Ngoy S, Romo GM.
between the levels of anti-HSP70 antibodies and the Rapid expression of heat shock protein in the rabbit after brief
cardiac ischemia. J Clin Invest 1991; 87: 139–147.presence of vascular diseases. It is not clear at present
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to the constitutive 73kD member of the HSP70 family of heat
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protein in autoimmune thyroid disease. J Clin Endocrinol Metab
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work is needed to see whether blocking the action of 20 Berberian PA, Myers W, Tytell M, Challa V, Bond MG.
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